首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients
被引:6
作者
:
Niparuck, Pimjai
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Niparuck, Pimjai
[
1
]
Kanoksil, Wasana
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Kanoksil, Wasana
Chuncharunee, Suporn
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Chuncharunee, Suporn
[
1
]
论文数:
引用数:
h-index:
机构:
Boonsakan, Paisarn
Ungkanont, Artit
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Ungkanont, Artit
[
1
]
Angchaisuksiri, Pantep
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Angchaisuksiri, Pantep
[
1
]
Karntisaviwat, Kanlaya
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Dept Pathol, Ramathibodi Hosp, Div Human Genet, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Karntisaviwat, Kanlaya
[
2
]
Apilugsanachit, Axara
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Dept Pathol, Ramathibodi Hosp, Div Human Genet, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Apilugsanachit, Axara
[
2
]
Rerkamnuatchoke, Budsaba
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Dept Pathol, Ramathibodi Hosp, Div Human Genet, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Rerkamnuatchoke, Budsaba
[
2
]
Jootar, Saengsuree
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Jootar, Saengsuree
[
1
]
Nitiyanant, Prawat
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Nitiyanant, Prawat
Atichartakarn, Vichai
论文数:
0
引用数:
0
h-index:
0
机构:
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
Atichartakarn, Vichai
[
1
]
机构
:
[1]
Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
[2]
Mahidol Univ, Dept Pathol, Ramathibodi Hosp, Div Human Genet, Bangkok 10700, Thailand
来源
:
LEUKEMIA & LYMPHOMA
|
2010年
/ 51卷
/ 11期
关键词
:
RITUXIMAB;
D O I
:
10.3109/10428194.2010.505675
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:2120 / 2125
页数:6
相关论文
共 8 条
[1]
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
Byrd, JC
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Byrd, JC
Peterson, BL
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Peterson, BL
Morrison, VA
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Morrison, VA
Park, K
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Park, K
Jacobson, R
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Jacobson, R
Hoke, E
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Hoke, E
Vardiman, JW
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Vardiman, JW
Rai, K
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Rai, K
Schiffer, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Schiffer, CA
Larson, RA
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Larson, RA
[J].
BLOOD,
2003,
101
(01)
: 6
-
14
[2]
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the, cytotoxic activity of either drug alone
Di Gaetano, N
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Di Gaetano, N
Xiao, Y
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Xiao, Y
Erba, E
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Erba, E
Bassan, R
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Bassan, R
Rambaldi, A
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Rambaldi, A
Golay, J
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Golay, J
Introna, M
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Introna, M
[J].
BRITISH JOURNAL OF HAEMATOLOGY,
2001,
114
(04)
: 800
-
809
[3]
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
McLaughlin, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
McLaughlin, P
Estey, E
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Estey, E
Glassman, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Glassman, A
Romaguera, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Romaguera, J
Samaniego, F
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Samaniego, F
Ayala, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Ayala, A
Hayes, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Hayes, K
Maddox, AM
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Maddox, AM
Preti, HA
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Preti, HA
Hagemeister, FB
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Hagemeister, FB
[J].
BLOOD,
2005,
105
(12)
: 4573
-
4575
[4]
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma
Misgeld, E
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Misgeld, E
Germing, U
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Germing, U
Aul, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Aul, C
Gattermann, N
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Gattermann, N
[J].
LEUKEMIA RESEARCH,
2001,
25
(01)
: 95
-
98
[5]
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011
Morrison, VA
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Morrison, VA
Rai, KR
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Rai, KR
Peterson, BL
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Peterson, BL
Kolitz, JE
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Kolitz, JE
Elias, L
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Elias, L
Appelbaum, FR
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Appelbaum, FR
Hines, JD
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Hines, JD
Shepherd, L
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Shepherd, L
Larson, RA
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Larson, RA
Schiffer, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Schiffer, CA
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2002,
20
(18)
: 3878
-
3884
[6]
TAM SC, 2006, HEMATOLOGICA, V91, P1546
[7]
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
Wierda, W
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Wierda, W
O'Brien, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
O'Brien, S
Wen, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Wen, S
Faderl, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Faderl, S
Garcia-Manero, G
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Garcia-Manero, G
Thomas, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Thomas, D
Do, KA
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Do, KA
Cortes, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Cortes, J
Koller, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Koller, C
Beran, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Beran, M
Ferrajoli, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Ferrajoli, A
Giles, F
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Giles, F
Lerner, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Lerner, S
Albitar, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Albitar, M
Kantarjian, H
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Kantarjian, H
Keating, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Keating, M
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005,
23
(18)
: 4070
-
4078
[8]
Yamauchi T, 2001, CLIN CANCER RES, V7, P3580
←
1
→
共 8 条
[1]
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
Byrd, JC
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Byrd, JC
Peterson, BL
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Peterson, BL
Morrison, VA
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Morrison, VA
Park, K
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Park, K
Jacobson, R
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Jacobson, R
Hoke, E
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Hoke, E
Vardiman, JW
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Vardiman, JW
Rai, K
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Rai, K
Schiffer, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Schiffer, CA
Larson, RA
论文数:
0
引用数:
0
h-index:
0
机构:
Ohio State Univ, Div Hematol Oncol, Dept Med, Columbus, OH 43210 USA
Larson, RA
[J].
BLOOD,
2003,
101
(01)
: 6
-
14
[2]
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the, cytotoxic activity of either drug alone
Di Gaetano, N
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Di Gaetano, N
Xiao, Y
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Xiao, Y
Erba, E
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Erba, E
Bassan, R
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Bassan, R
Rambaldi, A
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Rambaldi, A
Golay, J
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Golay, J
Introna, M
论文数:
0
引用数:
0
h-index:
0
机构:
Ist Ric Farmacol Mario Negri, Lab Mol Immunohaematol, I-20157 Milan, Italy
Introna, M
[J].
BRITISH JOURNAL OF HAEMATOLOGY,
2001,
114
(04)
: 800
-
809
[3]
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
McLaughlin, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
McLaughlin, P
Estey, E
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Estey, E
Glassman, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Glassman, A
Romaguera, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Romaguera, J
Samaniego, F
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Samaniego, F
Ayala, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Ayala, A
Hayes, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Hayes, K
Maddox, AM
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Maddox, AM
Preti, HA
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Preti, HA
Hagemeister, FB
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
Hagemeister, FB
[J].
BLOOD,
2005,
105
(12)
: 4573
-
4575
[4]
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma
Misgeld, E
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Misgeld, E
Germing, U
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Germing, U
Aul, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Aul, C
Gattermann, N
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
Gattermann, N
[J].
LEUKEMIA RESEARCH,
2001,
25
(01)
: 95
-
98
[5]
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011
Morrison, VA
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Morrison, VA
Rai, KR
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Rai, KR
Peterson, BL
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Peterson, BL
Kolitz, JE
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Kolitz, JE
Elias, L
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Elias, L
Appelbaum, FR
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Appelbaum, FR
Hines, JD
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Hines, JD
Shepherd, L
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Shepherd, L
Larson, RA
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Larson, RA
Schiffer, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Vet Affairs Med Ctr, Sect Hematol, Minneapolis, MN 55417 USA
Schiffer, CA
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2002,
20
(18)
: 3878
-
3884
[6]
TAM SC, 2006, HEMATOLOGICA, V91, P1546
[7]
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
Wierda, W
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Wierda, W
O'Brien, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
O'Brien, S
Wen, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Wen, S
Faderl, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Faderl, S
Garcia-Manero, G
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Garcia-Manero, G
Thomas, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Thomas, D
Do, KA
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Do, KA
Cortes, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Cortes, J
Koller, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Koller, C
Beran, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Beran, M
Ferrajoli, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Ferrajoli, A
Giles, F
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Giles, F
Lerner, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Lerner, S
Albitar, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Albitar, M
Kantarjian, H
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Kantarjian, H
Keating, M
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Keating, M
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005,
23
(18)
: 4070
-
4078
[8]
Yamauchi T, 2001, CLIN CANCER RES, V7, P3580
←
1
→